Future vaccines and a global perspective

Lancet

Volumn 350, Issue 9093, 1997, Pages 1767-1770

  Katz, Samuel L ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

BIOTECHNOLOGY; CHILD CARE; CONTAMINATION; DEVELOPING COUNTRY; GENETIC ENGINEERING; HEALTH CARE FINANCING; HEALTH CARE POLICY; HUMAN; IMMUNIZATION; INFECTION; NEEDLE; POLITICS; PREGNANCY; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; SOCIAL WELFARE; SYRINGE; VACCINATION;

EID: 0031581578     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)05358-0     Document Type: Review

References (24)

1. Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996; 271: 324-28.
2. Russell PK, Howson CP. Vaccines against malaria: hope in a gathering storm. Washington, DC: National Academy Press, 1996.
3. Stoute JA, Slaoui M, Heppner DG, et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N Engl J Med 1997; 336: 86-91.
4. Foulds J. The Comstock conference on tuberculosis vaccines. ASM News 1997; 63: 256-58.
5. Edelman R. The seventh interational congress on Lyme borreliosis: progress on the development of Lyme disease vaccines. Vaccine 1997; 15: 463-64.
6. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349: 1269-76.
7. Clemens J, Brenner R, Rao M, Tafari N, Lowe C. Evaluating new vaccines for developing countries. JAMA 1996; 275: 390-97.
8. Insel RA, Amstey M, Woodin K, Pichichero M. Maternal immunization to prevent infectious diseases in the neonate or infant. Int J Tech Assessment Health Care 1994; 10: 143-53.
9. CDC. Hepatitis B vaccination of adolescents - California, Louisiana and Oregon 1992-94. MMWR 1994; 43: 605-09.
10. Fiebach N, Beckett W. Prevention of respiratory infections in adults -influenza and pneumococcal vaccines. Arch Intern Med 1994; 154: 2545-57.
11. Alonso MJ, Gupta RK, Caroline M, Siber GR, Langer R. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 1994; 12: 299-306.
12. Rabinovich NR, McInnes P, Klein DL, Hall BF. Vaccine technologies: view to the future. Science 1994; 265: 1401-40.
13. Gupta RK, Siber GR. Adjuvants for human vaccines - current status, problems and future prospects. Vaccine 1995; 13: 1263-76.
14. Steinhoff MC. Haemophilus influenzae type b infections are preventable everywhere. Lancet 1997; 349: 1186-87.
15. Mulholland K, Hilton S, Adegbola R, et al. Randomised trial of Haemophilus influenzae type b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997; 349: 1191-97.
16. Liu MA, Hilleman MR, Kurth R. DNA vaccines, a new era in vaccinology. Annals NY Acad Sci 1995; 772: 1-294.
17. Brown F, Norrby E, Burton D, Mekalanos J. Molecular approaches to the control of infectious diseases. Cold Spring Harbour: Laboratory Press, 1996: 1-364.
18. McDonnell WM, Askari FK. Molecular medicine - DNA vaccines. N Engl J Med 1996; 334: 42-45.
19. Mitchell VS, Philipose NM, Sanford JP. Institute of Medicine. The Children's Vaccine Initiative. Washington, DC: National Academy Press, 1993: 1-221.
20. Thanavala Y, Yang Y-F, Lyons P, Mason HS, Arntzen CJ. Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc Natl Acad Sci 1995; 92: 3358-61.
21. Arntzen CJ. Edible vaccines produced in transgenic plants. The Jordan Report - Accelerated development of vaccines 1996. Bethesda: NIH, 43-48.
22. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.
23. Zhen-Kuu P, Ikonomidis G, Lazenby A, Pardoll D, Paterson Y. A recombinant listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nature Med 1995; 1: 471-77.
24. Miller SD, Karpus WJ. The immunopathogenesis and regulation of T-cell mediated demyelinating diseases. Immunol Today 1994; 356-60.